Works by Jae Yun Song

Results: 53
    1
    2
    3
    4
    5
    6
    7
    8

    Corrigendum.

    Published in:
    Journal of International Medical Research, 2013, v. 41, n. 2, p. 299, doi. 10.1177/0300060513491038
    By:
    • Jae Yun, Song
    Publication type:
    Article
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    From the Beginning of the Korean Gynecologic Oncology Group to the Present and Next Steps.

    Published in:
    Cancers, 2024, v. 16, n. 19, p. 3422, doi. 10.3390/cancers16193422
    By:
    • Min, Kyung-Jin;
    • Kim, Nam Kyeong;
    • Song, Jae-Yun;
    • Choi, Min Chul;
    • Lee, Shin Wha;
    • Lee, Keun Ho;
    • Kim, Min Kyu;
    • Kang, Sokbom;
    • Choi, Chel Hun;
    • Lee, Jeong-Won;
    • Lee, Eun-Ju;
    • Eom, Keun-Yong;
    • Kim, Sang Wun;
    • Cho, Hanbyoul;
    • Lee, Sun Joo;
    • Lim, Myong Cheol;
    • Bae, Jaeman;
    • Yoo, Chong Woo;
    • Kim, Kidong;
    • Kim, Dae-Yeon
    Publication type:
    Article
    37
    38
    39
    40

    Somatic genomic landscape of East Asian epithelial ovarian carcinoma and its clinical implications from prospective clinical sequencing: A Korean Gynecologic Oncology Group study (KGOG 3047).

    Published in:
    International Journal of Cancer, 2022, v. 151, n. 7, p. 1086, doi. 10.1002/ijc.34150
    By:
    • Sa, Jason K.;
    • Kim, Jihye;
    • Kang, Sokbom;
    • Kim, Sang Wun;
    • Song, Taejong;
    • Shim, Seung‐Hyuk;
    • Choi, Min Chul;
    • No, Jae Hong;
    • Song, Jae‐Yun;
    • Kim, Deokhoon;
    • Kim, Yong‐Man;
    • Kim, Jae‐Hoon;
    • Lee, Jeong‐Won
    Publication type:
    Article
    41
    42
    43
    44
    45
    46
    47
    48

    Standard of care therapy with or without stereotactic ablative radiation therapy for recurrent ovarian cancer (SABR-ROC): a prospective randomized phase III trial (KGOG 3064/KROG 2204).

    Published in:
    Journal of Gynecologic Oncology, 2024, v. 35, p. 34, doi. 10.3802/jgo.2024.35.S2.P26
    By:
    • Yong Bae Kim;
    • Chan Woo Wee;
    • Hojin Kim;
    • Hwa Kyung Byun;
    • So-Jin Shin;
    • Jae Hong No;
    • Keun Ho Lee;
    • Myong Cheol Lim;
    • Jae-Weon Kim;
    • Won Kyung Cho;
    • Min Sun Kyung;
    • Jae Yun Song;
    • Kyung Jin Min;
    • Eun Ji Lee;
    • Seob Jeon;
    • Jae-Hoon Kim;
    • Young Seok Kim;
    • Ju-Won Roh;
    • Jong Hoon Lee;
    • Youngmin Choi
    Publication type:
    Article
    49

    A randomized phase II study of secondary cytoreductive surgery (CRS) in patients with relapsed ovarian cancer who have progressed on PARP inhibitor maintenance: Korean Gynecologic Oncology Group (KGOG 3067)/SOCCER-P trial.

    Published in:
    Journal of Gynecologic Oncology, 2024, v. 35, p. 21, doi. 10.3802/jgo.2024.35.S2.P3
    By:
    • Jung-Yun Lee;
    • Hyun-Woong Cho;
    • Jae-Weon Kim;
    • Jeong-Yeol Park;
    • Yoo Young Lee;
    • Myong Cheol Lim;
    • Sung-Jong Lee;
    • Kyung-Jin Min;
    • Jae Yun Song;
    • Kyung Jin Eoh;
    • Kwang Beom Lee;
    • Min Kyu Kim;
    • Seung-Hyuk Shim;
    • Yong Il Ji;
    • Yong-Joong Song
    Publication type:
    Article
    50